Cathepsin D in the malignant progression of neoplastic diseases (review)
- PMID: 1567172
Cathepsin D in the malignant progression of neoplastic diseases (review)
Abstract
Recent studies suggest that aspartic proteinase Cathepsin D may be implicated in the process of tumor invasion and metastasis. In fact several in vitro observations showed that this proteinase may facilitate the spread of neoplastic cells through different mechanisms related to its proteolytic activity, by acting at different levels of the metastatic cascade. Cathepsin D may promote tumor cell proliferation by acting as an autocrine mitogen through the activation of latent forms of growth factors or by interacting with growth factor receptors. The enzyme was also shown to be able to degrade in vitro extracellular matrix and to activate latent precursors forms of other proteinases involved in the invasive steps of the metastatic process. Although unequivocal proof of its active role in promoting these processes also in vivo has not been obtained so far, recent clinical observations which showed a positive correlation between levels of expression of Cathepsin D activity and malignant progression of some human neoplasms further support this hypothesis. These findings warrant extensive experimental and clinical studies to better assess the pathophysiological role of this acid proteinase in the spread of neoplastic diseases and suggest new and more selective therapeutic approaches to the treatment of human neoplasms.
Similar articles
-
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].C R Seances Soc Biol Fil. 1998;192(2):241-51. C R Seances Soc Biol Fil. 1998. PMID: 9841098 Review. French.
-
[Cathepsin D in diagnosis of neoplastic diseases].Postepy Hig Med Dosw. 1993;47(4):277-88. Postepy Hig Med Dosw. 1993. PMID: 8309853 Review. Polish.
-
Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.Oncogene. 2002 Aug 1;21(33):5127-34. doi: 10.1038/sj.onc.1205657. Oncogene. 2002. PMID: 12140763
-
Biological and clinical significance of cathepsin D in breast cancer metastasis.Stem Cells. 1996 Nov;14(6):642-50. doi: 10.1002/stem.140642. Stem Cells. 1996. PMID: 8948022 Review.
-
Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.Cancer Cells. 1990 Dec;2(12):383-8. Cancer Cells. 1990. PMID: 1965134 Review.
Cited by
-
Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.BMC Cancer. 2020 Aug 31;20(1):825. doi: 10.1186/s12885-020-07327-w. BMC Cancer. 2020. PMID: 32867726 Free PMC article.
-
Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.Virchows Arch. 1996 Jul;428(4-5):207-15. doi: 10.1007/BF00196692. Virchows Arch. 1996. PMID: 8764928
-
The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.Mol Biol Cell. 1993 Dec;4(12):1317-26. doi: 10.1091/mbc.4.12.1317. Mol Biol Cell. 1993. PMID: 8167412 Free PMC article.
-
Recent progress in the imaging detection of enzyme activities in vivo.RSC Adv. 2019 Aug 13;9(44):25285-25302. doi: 10.1039/c9ra04508b. eCollection 2019 Aug 13. RSC Adv. 2019. PMID: 35530057 Free PMC article. Review.
-
Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines.Breast Cancer Res Treat. 1995 Aug;35(2):211-20. doi: 10.1007/BF00668211. Breast Cancer Res Treat. 1995. PMID: 7647343
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources